Bill Information for SB 351

SB 351 by Hamilton

Select Session:

Enter Bill #:

Pharmacogenomic testing; requiring licensed practitioner to offer pharmacogenomic test prior to prescription of psychotropic drug. Effective date.

History

Amendments

Bill Summaries

Versions

Votes

Authors/Co Authors

History For SB 351
Action	Journal Page	Date	Chamber
First Reading	132	02/01/2021	S

Authored by Senator Hamilton	132	02/01/2021	S

Second Reading referred to Health and Human Services	306	02/02/2021	S

Floor Amendments (Senate)
None
Floor Amendments (House)
None
Committee Amendments (Senate)
None
Committee Amendments (House)
None
Sub Committee Recommendations (House)
None

Bill Summaries/Fiscal Impact for SB 351 (House)
None
Bill Summaries/Fiscal Impact for SB 351 (Senate)
Introduced	1/12/2021

OPLAA Actuarial Statements For SB 351 (House)
None
OPLAA Actuarial Statements For SB 351 (Senate)
None
Fiscal Impact Statements For SB 351 (House)
None
Fiscal Impact Statements For SB 351 (Senate)
None

Versions of SB 351
Introduced	1/11/2021

Committee Reports for SB 351
Conference Committee Reports for SB 351

Votes on SB 351
None

***To be added when the next official action is taken on the measure.***

Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105